ArticleBMC genomic data2026
Complete genome sequence of Leuconostoc lactis B34-1-7-1 isolated from Panax ginseng in South Korea.
Article in BMC genomic data, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Complete genome sequence of Leuconostoc lactis B34-1-7-1 isolated from Panax ginseng in South Korea.BMC genomic data · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
objectivesLeuconostoc lactis is a heterofermentative lactic acid bacterium widely used as a starter culture in fermented foods. The L. lactis B34-1-7-1 strain, isolated from Panax ginseng sprouts cultivated under white LED light, has demonstrated promising probiotic potential, including antioxidant, anti-inflammatory, and anti-cancer activities, in previous studies. The genome of L. lactis B34-1-7-1 was sequenced and analyzed to evaluate its probiotic potential and safety for industrial applications, focusing on its genomic features and functional characteristics. DATA DESCRIPTION: The genome of L. lactis B34-1-7-1 was sequenced using a hybrid Illumina-PacBio approach. The complete genome is composed of a circular chromosome (1,648,351 bp) and a plasmid (12,481 bp), with an overall guanine-cytosine (GC) content of 43.6%. The genome encodes 1,661 coding sequences (CDSs), 68 transfer RNAs, and 12 ribosomal RNAs. Functional classification assigned 99.15% (1,647 genes) of the CDSs to Clusters of Orthologous Groups (COGs). Genome-based screening identified no known antibiotic resistance genes or virulence factors, supporting the safety of this strain. In addition, 23 genes associated with reductase and oxidase activities were identified, providing a genetic basis for its observed antioxidant potential. These results provide a foundational genomic resource supporting the application of L. lactis B34-1-7-1 in the functional food and probiotic industries.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.